A review of Senate Estimates, with irritating warnings, too much passivity, and passive-aggressive responses (0.00-4.50). Revelations on how oral contraceptives navigated the funding process and the drivers of that outcome (4.51-14.10). We disagree on the role of advisory committees in policymaking (14.10-25.00). The impact of individuals in health policy, how change can have a significant effect, and we disagree again on advisory committees and policy (25.01-39.20). Officials confirmed the HTA-driven go-slow on newborn screening at Senate Estimates (39.20-49.20). The challenge of ensuring equitable access to the newly-reimbursed oral contraceptives, given the need for a new prescription (49.20-55.30) and some worrying new policy announcements (55.30-66.50).

Ver todos los episodios